Physician profile
Omar Y Kudsi
NPI 1356535744
$885,867.13
in general payments reported to CMS, 2019-2025
8 companies · $180K in 2025
The $180K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120K · 2020: $29K · 2021: $65K · 2022: $164K · 2023: $56K · 2024: $272K · 2025: $180K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $272K · Education: $141K · Consulting Fee: $68K · Travel and Lodging: $15K · Food and Beverage: $12K · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $272,033.34 |
| Education | $140,750.00 |
| Consulting Fee | $67,591.50 |
| Travel and Lodging | $15,422.97 |
| Food and Beverage | $11,966.04 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $706,006.10 | 2019-2025 | Da Vinci Sp, Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $176,646.77 | 2019-2025 | Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial, Gore Bio-A Tissue Reinforcement |
| Davol INC. | $1,576.48 | 2022-2025 | |
| Covidien Lp | $1,352.06 | 2019 | |
| Becton, Dickinson and Company | $172.37 | 2022-2024 | Phasix Mesh |
| Virtual Incision Corporation | $67.00 | 2024 | Mira |
| Heron Therapeutics, INC. | $46.35 | 2021-2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Kudsi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.